REVA Medical to Hold Briefing Call on Financial Results for 2011
February 22 2012 - 7:43PM
REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") will hold a
conference call to discuss the Company's financial results through
December 31, 2011 and its business outlook. Robert Stockman,
Chairman and CEO, will host the call.
The call is scheduled for 2:00 p.m. US PST on Wednesday,
February 29, 2012 (or 9:00 am AEDT on Thursday 1 March
2012) and may be accessed within the United States by
dialing 1-877-312-5413 five minutes prior to the scheduled
start time. For callers in Australia, please dial 2 8223
9876. A replay of the conference call will be available on
the Company's website following the call.
About REVA
REVA is a development stage medical device company incorporated
in Delaware, USA, that is focused on the development and eventual
commercialization of its proprietary, bioresorbable stent products.
REVA's lead product, the ReZolve™ scaffold, combines REVA's
proprietary stent design with a proprietary polymer that is
metabolized and cleared from the body. The ReZolve scaffold is
designed to offer full x-ray visibility, clinically relevant sizing
and a controlled and safe resorption rate. In addition, by early
encapsulation of the stent in the artery tissue coupled with the
loss of scaffold structure over time, the ReZolve scaffold may
reduce the incidence of late forming blood clots, or thrombosis, a
rare but serious problem associated with drug-eluting metal stents
currently on the market. REVA will require clinical results and
regulatory approval before it can begin selling the ReZolve
scaffold.
The REVA Medical, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=8505
CONTACT: United States
Investor and Media Enquiries:
Cheryl Liberatore
Director, Investor Relations and Marketing
REVA Medical, Inc.
+1 858 966-3045
Australia
Investor Enquiries:
David Allen or Alan Taylor
Inteq Limited
+61 2 9231 3322
Media Enquiries:
Katie Mackenzie or Rebecca Wilson
Buchan Consulting
+ 61 3 9866 4722
Reva Medical (ASX:RVA)
Historical Stock Chart
From Apr 2024 to May 2024
Reva Medical (ASX:RVA)
Historical Stock Chart
From May 2023 to May 2024